European mid-market private equity firm Inflexion is to sell its investment in Lintbells, a specialist in pet supplements which are sold under the YuMOVE brand name, to to Vetnique Labs, a portfolio company of Gryphon Investors.
The sale marks a highly successful exit for Inflexion Enterprise Fund IV, generating a 5.5x return.
Hertfordshire, UK-based Lintbells was founded almost two decades ago by Dr John Howie DL and John Davies, to provide pets and their owners with scientifically supported supplements to support chronic health conditions. Lintbells’ YuMOVE products a joint mobility supplements for dogs and cats, as well as supplements to support digestive health, anxiety, skin & coat and dental.
Since the 2017 investment, Inflexion’s in-house teams have supported Lintbells across a range of growth opportunities, including its expansion of the highly successful direct-to-consumer channel. Inflexion has also supported the successful expansion of Lintbells into the US both organically and through the acquisition of Walkin’ Pets.
In addition to Lintbells, Inflexion has significant experience in the pet-care market with previous successful investments including Medivet and Kynetec.
Can’t stop reading? Read more
Blackstone proposes $2.5bn investment in potential $4bn New World transaction
Blackstone proposes $2.5bn investment in potential $4bn New World transaction Blackstone has...
Searchlight-backed Roots explores sale as shares trade near $2.35
Searchlight-backed Roots explores sale as shares trade near $2.35 Searchlight Capital...
Kushner’s Thrive Capital and Andreessen lead $4bn Anduril round at $60bn valuation
Kushner's Thrive Capital and Andreessen lead $4bn Anduril round at $60bn valuation Thrive Capital...